Hydroxychloroquine News and Research

RSS
Hydroxychloroquine treatment not effective for primary Sjögren syndrome

Hydroxychloroquine treatment not effective for primary Sjögren syndrome

Research: Antibiotics for Q fever can contribute to obesity

Research: Antibiotics for Q fever can contribute to obesity

Anti-malaria drug combination may help prevent pregnancy complications in women with lupus

Anti-malaria drug combination may help prevent pregnancy complications in women with lupus

VG Life Sciences provides update to HCQ-sorafenib combination Phase I Study for advanced stage solid tumors

VG Life Sciences provides update to HCQ-sorafenib combination Phase I Study for advanced stage solid tumors

Women taking immunosuppressive medications during pregnancy do not put their babies at risk

Women taking immunosuppressive medications during pregnancy do not put their babies at risk

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Combination of three DMARDs more cost-effective in treating early rheumatoid arthritis

Combination of three DMARDs more cost-effective in treating early rheumatoid arthritis

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

Hydroxychloroquine fails to modify HIV in patients not taking ART

Hydroxychloroquine fails to modify HIV in patients not taking ART

Viral Genetics initiates Phase 1 trial of MDT compounds for ovarian cancer

Viral Genetics initiates Phase 1 trial of MDT compounds for ovarian cancer

Researchers develop potent new drug that can kill tumor cells

Researchers develop potent new drug that can kill tumor cells

Combination treatment effective against melanoma

Combination treatment effective against melanoma

Penn oncologist to discuss role of autophagy in fighting cancer at AAAS annual meeting

Penn oncologist to discuss role of autophagy in fighting cancer at AAAS annual meeting

Center for LAM Research and Clinical Care at BWH to conduct phase I combination drug trial

Center for LAM Research and Clinical Care at BWH to conduct phase I combination drug trial

Anti-TNFs, methotrexate may reduce risk of cardiovascular disease in people with RA

Anti-TNFs, methotrexate may reduce risk of cardiovascular disease in people with RA

Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis

Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis

Tofacitinib safe and effective for patients with rheumatoid arthritis

Tofacitinib safe and effective for patients with rheumatoid arthritis

Researchers classify chronic ulcerative stomatitis as a new autoimmune disease

Researchers classify chronic ulcerative stomatitis as a new autoimmune disease

Combination of molecularly targeted cancer drug and anti-malarial drug stops tumor growth

Combination of molecularly targeted cancer drug and anti-malarial drug stops tumor growth

Glasgow Professor discusses about new approach for CML treatment at UK conference

Glasgow Professor discusses about new approach for CML treatment at UK conference

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.